Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS)
$ 0.0371 0.0001 (0.27%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 1.45 GF Score: 16/100

Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript

Jul 25, 2022 / 09:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Zymergen Business Update Conference Call. (Operator Instructions)

I would now like to turn the conference to your host, Ms. Carrie Mendivil with Investor Relations. Please go ahead.

Carrie Mendivil

Thank you. Earlier today, Zymergen issued a joint press release with Ginkgo Bioworks announcing a definitive merger agreement for Ginkgo to acquire Zymergen. Joining me today to discuss this announcement as well as other organizational updates is Jay Flatley, acting Chief Executive Officer of Zymergen.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.

Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release Ginko Bioworks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot